HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-(Piperidin-4-yl)quinoxaline → 2-{1-[4-(6-Phenyl-imidazo[1,2-a]pyrimidin-7-yl)-benzyl]-piperidine-4-yl}-quinoxaline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-(Piperidin-4-yl)quinoxaline | HCID 21198026 | — |
| Reactant | 4-(6-Phenylimidazo[1,2-a]pyrimidin-7-yl)benzaldehyde | HCID 86630655 | — |
| Product | 2-{1-[4-(6-Phenyl-imidazo[1,2-a]pyrimidin-7-yl)-benzyl]-piperidine-4-yl}-quinoxaline | HCID 68751737 | 33.2% |
Reaction Steps
160 mg (0.53 mmol) 4-(6-phenylimidazo[1,2-a]pyrimidin-7-yl)benzaldehyde and 182 mg (0.64 mmol) 2-piperidine-4-yl-quinoxaline were reacted for two days at room temperature and purified as described in example 6.0. 87.3 mg of the desired compound were obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08957064B2 |
| Source dataset | uspto-grants-2015_02 |
| ORD ID | ord-56196640d83f458796e3f105b4258778 |
| Source note | uspto-grants-2015_02 |